Cargando…
597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors
BACKGROUND: Inpatient HIV-related medication errors occur in up to 86% of patients. The purpose of this study was to evaluate the number of antiretroviral therapy (ART)- and opportunistic infection (OI)-related medication errors following the implementation of pharmacist-directed interventions. METH...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254135/ http://dx.doi.org/10.1093/ofid/ofy210.604 |
_version_ | 1783373654578429952 |
---|---|
author | Wingler, Mary Joyce B Stover, Kayla R Barber, Katie E Wagner, Jamie L |
author_facet | Wingler, Mary Joyce B Stover, Kayla R Barber, Katie E Wagner, Jamie L |
author_sort | Wingler, Mary Joyce B |
collection | PubMed |
description | BACKGROUND: Inpatient HIV-related medication errors occur in up to 86% of patients. The purpose of this study was to evaluate the number of antiretroviral therapy (ART)- and opportunistic infection (OI)-related medication errors following the implementation of pharmacist-directed interventions. METHODS: This quasi-experiment assessed adult patients with HIV who received ART, OI prophylaxis, or both from December 1, 2014 to February 28, 2017 (pre-intervention) or December 1, 2017 to February 28, 2018 (post-intervention). Pre-intervention patients were assessed retrospectively, verbal and written education were provided, then prospective audit and feedback was conducted for post-intervention patients. The primary outcome was rate of ART-related medication errors in the pre- vs. post-intervention groups. Secondary outcomes included time to resolution of ART- and OI-related medication errors, OI-related medication errors, types of errors, rate of acceptance of recommendations, in-hospital mortality, length of stay, and 30-day readmission. RESULTS: Sixty-seven patients were included in each group (pre- and post-intervention). ART errors occurred in 44.8% and 32.8% (P = 0.156), respectively. OI prophylaxis errors occurred in 11.9% vs. 9% (P = 0.572), respectively. No difference was found in types of errors between groups, except medication omission decreased significantly in the post-intervention group (31.3% vs. 11.9%; P = 0.006). The number of pharmacist-based interventions increased in the post-intervention group (6.3% vs. 52.9%; P = 0.001). No statistical difference was found in average time to error resolution (72 vs. 48 hours; P = 0.123), but errors resolved during admission significantly increased (50% vs. 86.8%; P < 0.001). No difference was found in rate of intervention acceptance, which was high in both groups. CONCLUSION: In this quasi-experiment, ART and OI prophylaxis medication errors were numerically reduced in the pharmacist-led intervention period, and medication errors were resolved a day faster in the post-intervention period. Future interventions targeting prescribing errors upon admission include follow-up education and evaluation of medication reconciliation practices in HIV-infected patients. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6254135 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62541352018-11-28 597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors Wingler, Mary Joyce B Stover, Kayla R Barber, Katie E Wagner, Jamie L Open Forum Infect Dis Abstracts BACKGROUND: Inpatient HIV-related medication errors occur in up to 86% of patients. The purpose of this study was to evaluate the number of antiretroviral therapy (ART)- and opportunistic infection (OI)-related medication errors following the implementation of pharmacist-directed interventions. METHODS: This quasi-experiment assessed adult patients with HIV who received ART, OI prophylaxis, or both from December 1, 2014 to February 28, 2017 (pre-intervention) or December 1, 2017 to February 28, 2018 (post-intervention). Pre-intervention patients were assessed retrospectively, verbal and written education were provided, then prospective audit and feedback was conducted for post-intervention patients. The primary outcome was rate of ART-related medication errors in the pre- vs. post-intervention groups. Secondary outcomes included time to resolution of ART- and OI-related medication errors, OI-related medication errors, types of errors, rate of acceptance of recommendations, in-hospital mortality, length of stay, and 30-day readmission. RESULTS: Sixty-seven patients were included in each group (pre- and post-intervention). ART errors occurred in 44.8% and 32.8% (P = 0.156), respectively. OI prophylaxis errors occurred in 11.9% vs. 9% (P = 0.572), respectively. No difference was found in types of errors between groups, except medication omission decreased significantly in the post-intervention group (31.3% vs. 11.9%; P = 0.006). The number of pharmacist-based interventions increased in the post-intervention group (6.3% vs. 52.9%; P = 0.001). No statistical difference was found in average time to error resolution (72 vs. 48 hours; P = 0.123), but errors resolved during admission significantly increased (50% vs. 86.8%; P < 0.001). No difference was found in rate of intervention acceptance, which was high in both groups. CONCLUSION: In this quasi-experiment, ART and OI prophylaxis medication errors were numerically reduced in the pharmacist-led intervention period, and medication errors were resolved a day faster in the post-intervention period. Future interventions targeting prescribing errors upon admission include follow-up education and evaluation of medication reconciliation practices in HIV-infected patients. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6254135/ http://dx.doi.org/10.1093/ofid/ofy210.604 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Wingler, Mary Joyce B Stover, Kayla R Barber, Katie E Wagner, Jamie L 597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors |
title | 597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors |
title_full | 597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors |
title_fullStr | 597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors |
title_full_unstemmed | 597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors |
title_short | 597. Pharmacist-Led Interventions for Inpatient HIV-Related Medication Errors |
title_sort | 597. pharmacist-led interventions for inpatient hiv-related medication errors |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254135/ http://dx.doi.org/10.1093/ofid/ofy210.604 |
work_keys_str_mv | AT winglermaryjoyceb 597pharmacistledinterventionsforinpatienthivrelatedmedicationerrors AT stoverkaylar 597pharmacistledinterventionsforinpatienthivrelatedmedicationerrors AT barberkatiee 597pharmacistledinterventionsforinpatienthivrelatedmedicationerrors AT wagnerjamiel 597pharmacistledinterventionsforinpatienthivrelatedmedicationerrors |